Patient-Centered PI, MD — Clinical Trials Leader

Civia Health, LLC.; Shelby Charter Township (MI); Sur place; USD 140 000 - 200 000; Plein temps

Avantages offerts par ce poste

Competitive pay

Health coverage (Medical, dental, vizn

Résumé du poste

Civia Health seeks an experienced Principal Investigator (MD/DO) to oversee Phase 2–4 clinical trials, ensuring scientific integrity, patient safety, and regulatory compliance. You will lead clinical oversight as the physician of record for assigned studies and mentor the research team.

You'll review study protocols, consent documents, and source data, while coordinating with sponsors, monitors, and IRBs. Occasional travel for audits and visits is expected.

Qualifications

• MD/DO with active license
• 3+ years as Principal Investigator in clinical research (Phase 2–4 preferred)
• Board certification in internal medicine/endocrinology or related field preferred

Responsabilités

• Serve as the physician of record and lead clinical oversight for assigned trials.
• Review and approve study protocols, informed consent documents, and source documentation.
• Conduct physical exams, medical reviews, and oversee safety assessments for participants.
• Ensure compliance with all ICH-GCP, FDA, and IRB regulations.
• Provide guidance and mentorship to the clinical research team.
• Engage with sponsors, monitors, and regulatory bodies as needed.
• Occasional travel may be required for audits, site visits, or team meetings.

Connaissances

Leadership

Communication

Problem-solving

Patient-centered care

Formation

MD/DO degree

Board certification preferred

Outils

GCP knowledge

FDA regulations

Clinical operations

Description du poste

Civia Health seeks an experienced Principal Investigator (MD/DO) to oversee Phase 2–4 clinical trials, ensuring scientific integrity, patient safety, and regulatory compliance. You will lead clinical oversight as the physician of record for assigned studies and mentor the research team.

You'll review study protocols, consent documents, and source data, while coordinating with sponsors, monitors, and IRBs. Occasional travel for audits and visits is expected.